Results 51 to 60 of about 177 (68)

Antifungal Development and the Urgency of Minimizing the Impact of Fungal Diseases on Public Health. [PDF]

ACS Bio Med Chem Au, 2023
de Oliveira HC, Bezerra BT, Rodrigues ML.   +2 more
europepmc   +1 more source

Anti-<i>Aspergillus</i> activities of olorofim at sub-MIC levels during early-stage growth. [PDF]

Microbiol Spectr
Kühbacher A, Birch M, Oliver JD, Gsaller F.   +3 more
europepmc   +1 more source

Antifungal and fungicide susceptibility of clinical, animal, and environmental Fusarium and Neocosmospora species from Colombia: a one-health approach. [PDF]

Sci Rep
Saenz V, Lizcano-Salas AF, Le Pape P, Celis Ramírez AM.   +3 more
europepmc   +1 more source

A case of Lomentospora prolificans endophthalmitis treated with the novel antifungal agent Olorofim. [PDF]

J Ophthalmic Inflamm Infect
Dong M, Pearce F, Singh N, Lin ML.
europepmc   +1 more source

Old and new strategies in therapy and diagnosis against fungal infections. [PDF]

Appl Microbiol Biotechnol
Vanzolini T, Magnani M.
europepmc   +1 more source

Olorofim activity against multidrug-resistant Fusarium unveils intra-species and inter-species variability. [PDF]

Antimicrob Agents Chemother
Xue R, Gao S, de Hoog S, van Diepeningen A, Zhou S, Xu T, Fokkens L, Li R, Bai L, Wan Z, Verweij PE, Song Y.   +11 more
europepmc   +1 more source

New antifungal strategies and drug development against WHO critical priority fungal pathogens. [PDF]

Front Cell Infect Microbiol
Li Y, Liu Y, Jiang Y, Yang Y, Ni W, Zhang W, Tan L.   +6 more
europepmc   +1 more source

cyp51A Mutations, Extrolite Profiles, and Antifungal Susceptibility in Clinical and Environmental Isolates of the Aspergillus viridinutans Species Complex. [PDF]

Antimicrob Agents Chemother, 2019
Talbot JJ, Frisvad JC, Meis JF, Hagen F, Verweij PE, Hibbs DE, Lai F, Groundwater PW, Samson RA, Kidd SE, Barrs VR, Houbraken J.   +11 more
europepmc   +1 more source

The Orotomide Olorofim Is Efficacious in an Experimental Model of Central Nervous System Coccidioidomycosis. [PDF]

Antimicrob Agents Chemother, 2018
Wiederhold NP, Najvar LK, Jaramillo R, Olivo M, Birch M, Law D, Rex JH, Catano G, Patterson TF.   +8 more
europepmc   +1 more source

Meeting the Therapeutic Challenges of Emergent and Rare Invasive Fungal Diseases Through Novel Clinical Trial Designs. [PDF]

Open Forum Infect Dis
Walsh TJ.
europepmc   +1 more source